Global Salbutamol Sales Market Report 2021

Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and S-isomers. The R-isomer has 150 times greater affinity for the beta2-receptor than the S-isomer and the S-isomer has been associated with toxicity. This lead to the development of levalbuterol, the single R-isomer of salbutamol. However, the high cost of levalbuterol compared to salbutamol has deterred wide-spread use of this enantiomerically pure version of the drug. Salbutamol is generally used for acute episodes of bronchospasm caused by bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders such as chronic obstructive pulmonary disorder (COPD). It is also used prophylactically for exercise-induced asthma.

Market Analysis and Insights: Global Salbutamol Market
The global Salbutamol market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Salbutamol Scope and Market Size
The global Salbutamol market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Salbutamol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Solution
Aerosol
Aerosol, Spray
Inhalant

Segment by Application
Human
Animal

The Salbutamol market is analysed and market size information is provided by regions (countries). Segment by Application, the Salbutamol market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Mylan
Armstrong Pharmaceuticals
GlaxoSmithKline
3M Pharmaceuticals Inc
Novex
Apotex
Teva Pharmaceuticals